| SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer (NCT05300269) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-07-05 |
| Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial (NCT05877352) | University Hospital Southampton NHS Foundation Trust | 2022-05-18 |
| Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer (NCT05245474) | Beijing Friendship Hospital | 2022-04-01 |
| Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 (NCT05253846) | Gruppo Oncologico del Nord-Ovest | 2022-01-25 |
| Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer (NCT05079503) | Korean Cancer Study Group | 2021-12-15 |
| PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting (NCT05076305) | St Vincent's University Hospital, Ireland | 2021-10-15 |
| Dendrobium Huoshanense Suppository in Rectal Cancer (NCT05079438) | Zhejiang Cancer Hospital | 2021-09-07 |
| Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer (NCT05086627) | Hebei Medical University Fourth Hospital | 2021-09-01 |
| A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery (NCT04948762) | St Vincent's University Hospital, Ireland | 2021-08-01 |
| Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score (NCT04989855) | Sun Yat-sen University | 2021-08-01 |
| Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence (NCT05054959) | Institute of Oncology Ljubljana | 2021-06-24 |
| Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer (NCT04906044) | The First Hospital of Jilin University | 2021-06-01 |
| Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer (NCT04518280) | Fudan University | 2021-05-01 |
| THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy (NCT04815694) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-03-17 |
| Development of a Genome-based Platform for Personalized Treatment in Locally Advanced Rectal Cancer Patients (NCT04738214) | Yonsei University | 2021-02-01 |
| Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer (NCT04663763) | Zhejiang Cancer Hospital | 2020-12-01 |
| The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer (NCT04411524) | Fudan University | 2020-07-01 |
| The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer (NCT04411537) | Fudan University | 2020-07-01 |
| A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC (NCT04423965) | First Affiliated Hospital of Zhejiang University | 2020-05-12 |
| A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer (NCT04394598) | Fudan University | 2020-03-01 |
| Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial (NCT04177602) | Universitätsklinikum Hamburg-Eppendorf | 2019-11-04 |
| Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer (NCT04324567) | Oslo University Hospital | 2019-10-09 |
| Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer (NCT03916510) | University of Oxford | 2019-07-29 |
| Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer (NCT03770689) | EMD Serono Research & Development Institute, Inc. | 2019-03-20 |
| Evaluation of Efficacy, Quality of Life and Cost Effectiveness of Short-course Radiotherapy Followed by Capecitabine Plus Oxaliplatin chemotheRapy and TME for High-risk Rectal Cancer (ESCORT Trial) (NCT03676517) | Yonsei University | 2019-03-01 |
| Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer (NCT04170530) | First Affiliated Hospital of Zhejiang University | 2019-01-01 |
| UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer (NCT03824899) | Fudan University | 2018-10-10 |
| Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test. (NCT03699410) | Dimitri Christoforidis | 2018-08-28 |
| Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma (NCT03503630) | Ali Shamseddine | 2018-07-20 |
| Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer (NCT03702985) | Fudan University | 2018-05-28 |
| Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer (NCT03040180) | Zealand University Hospital | 2017-01-01 |
| Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters (NCT03392584) | Oslo University Hospital | 2016-10-01 |
| Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer (NCT02964468) | Grupo de Investigación Clínica en Oncología Radioterapia | 2016-09-01 |
| Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer (NCT03443661) | Aiping Zhou | 2016-02-06 |
| Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 (NCT02605265) | Fudan University | 2015-10-01 |
| Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer (NCT06293612) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2015-01-01 |
| Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision (NCT02167321) | Yonsei University | 2014-12-01 |
| Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial (NCT02290574) | Samsung Medical Center | 2014-11-01 |
| Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer (NCT02151019) | Cancer Trials Ireland | 2014-10-17 |
| Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis (NCT03149978) | Zhu Ji | 2014-07-01 |
| Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer (NCT01899118) | Zhejiang Cancer Hospital | 2013-04-01 |
| Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics (NCT03238885) | Sun Ying-Shi | 2013-03-01 |
| Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer (NCT02353858) | University Hospital Tuebingen | 2012-08-01 |
| A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer (NCT01589419) | AbbVie (prior sponsor, Abbott) | 2012-06-01 |
| The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness (NCT01859442) | Michelle Mossa | 2012-01-01 |
| Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision. (NCT03034473) | University Medical Center Goettingen | 2011-08-01 |
| Evaluation of Inflammatory Markers in LARC Patients (NCT05893667) | Hospital Pedro Hispano | 2010-01-01 |
| Minimal Invasive Strategies for Good and Complete Response to Chemoradiation in Rectal Cancer (NCT00939666) | Maastricht University Medical Center | 2009-07-01 |
| Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer (NCT00828672) | Universitaire Ziekenhuizen KU Leuven | 2009-06-01 |
| Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study (NCT00842686) | Institute of Oncology Ljubljana | 2009-01-01 |
| Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal Cancer (NCT00931203) | National Health Research Institutes, Taiwan | 2008-07-01 |